Ermenegildo Zegna NV
ZGN
Hutchmed (China)
HCM
eBay
EBAY
Enerpac Tool
EPAC
Halozyme Therapeutics
HALO
US Stock MarketDetailed Quotes
CAPR Capricor Therapeutics
- 11.815
- -1.365-10.36%
Close Mar 27 16:00 ET
- 11.850
- +0.035+0.30%
Post 20:01 ET
539.66MMarket Cap-10.27P/E (TTM)
13.810High11.810Low1.96MVolume13.330Open13.180Pre Close24.46MTurnover4.89%Turnover RatioLossP/E (Static)45.68MShares23.40052wk High3.71P/B474.32MFloat Cap3.52052wk Low--Dividend TTM40.15MShs Float7999.998Historical High--Div YieldTTM15.18%Amplitude0.880Historical Low12.450Avg Price1Lot Size
Capricor Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -56.25%-40M | -27.62%-14.8M | -32.38%-11.64M | -30.48%-12.29M | -130.13%-1.27M | -620.61%-25.6M | -67.98%-11.59M | -54.69%-8.79M | -43.95%-9.42M | -82.49%4.21M |
| Net income from continuing operations | -81.57%-40.47M | -833.83%-7.12M | -96.49%-12.56M | -49.32%-11M | -26.08%-9.79M | 23.20%-22.29M | 90.13%-762.09K | -0.31%-6.39M | -3.62%-7.37M | 0.64%-7.77M |
| Operating gains losses | 1,767.32%112.81K | ---- | ---- | ---- | ---- | -82.37%6.04K | --653 | ---- | ---- | ---- |
| Depreciation and amortization | 33.34%1.43M | 22.14%375.71K | 30.64%361.17K | 40.14%356.94K | 44.03%331.41K | 100.49%1.07M | 60.55%307.61K | 101.76%276.47K | 127.39%254.7K | 148.78%230.1K |
| Other non cash items | -94.63%-47.26K | -57.51%-16.32K | -956.24%-10.74K | -56.53%-10.1K | -56.54%-10.1K | -115.01%-24.28K | -59.06%-10.36K | -104.46%-1.02K | -108.87%-6.45K | -108.87%-6.45K |
| Change In working capital | 8.23%-10.78M | 19.58%-10.45M | 66.21%-1.49M | 3.31%-3.79M | -48.34%4.94M | -140.88%-11.75M | -2,267.67%-12.99M | -684.10%-4.4M | -405.24%-3.92M | -68.79%9.56M |
| -Change in receivables | 100.04%3.5K | -1.37%-9.96M | ---39.71K | ---975 | --10M | -6,204.57%-9.82M | ---9.82M | --0 | --0 | --0 |
| -Change in prepaid assets | -504.41%-458.65K | -99.00%-1.07M | 260.52%452.15K | -0.90%288.63K | -390.33%-130.07K | -131.61%-75.88K | 6.74%-537.36K | -60.26%125.42K | 2.56%291.26K | -79.33%44.8K |
| -Change in payables and accrued expense | 46.35%1.94M | 406.44%1.66M | -78.20%361.43K | 73.03%-78.72K | -100.32%-1.58K | 9.78%1.33M | -154.86%-541.71K | 132.06%1.66M | 66.69%-291.92K | 31.14%501.82K |
| -Change in other current assets | ---- | ---- | --312 | ---25.84K | ---25.55K | ---- | ---- | --0 | --0 | --0 |
| -Change in other working capital | -286.10%-12.27M | 45.86%-1.13M | 63.44%-2.26M | -1.38%-3.97M | -154.44%-4.91M | -111.58%-3.18M | -117.53%-2.09M | -288.66%-6.19M | ---3.92M | -69.96%9.01M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -56.25%-40M | -27.62%-14.8M | -32.38%-11.64M | -30.48%-12.29M | -130.13%-1.27M | -620.61%-25.6M | -67.98%-11.59M | -54.69%-8.79M | -43.95%-9.42M | -82.49%4.21M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -2,374.45%-116.18M | -2,004.53%-123.38M | -74.04%2M | 127.43%14.7M | -195.86%-9.5M | 114.56%5.11M | -214.01%-5.86M | 284.87%7.72M | 118.25%6.46M | -413.58%-3.21M |
| Net PPE purchase and sale | 24.84%-1.54M | -0.75%-734.72K | 90.66%-59.03K | 65.34%-80.91K | -46.61%-664.32K | 39.06%-2.05M | 40.35%-729.22K | 42.53%-631.75K | 43.42%-233.44K | 27.54%-453.12K |
| Net investment purchase and sale | -1,702.14%-114.64M | -2,289.18%-122.65M | -75.29%2.06M | 120.71%14.78M | -220.37%-8.84M | 122.56%7.16M | -180.66%-5.13M | 371.44%8.35M | 119.13%6.69M | ---2.76M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -2,374.45%-116.18M | -2,004.53%-123.38M | -74.04%2M | 127.43%14.7M | -195.86%-9.5M | 114.56%5.11M | -214.01%-5.86M | 284.87%7.72M | 118.25%6.46M | -413.58%-3.21M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 497.23%152.77M | 250.01%81.09M | 30,353.48%67.33M | -5.53%2.07M | 58,699.59%2.29M | 424.84%25.58M | 685.45%23.17M | -88.25%221.08K | 14,481.33%2.19M | -85.82%3.9K |
| Net common stock issuance | 496.98%152.32M | 248.99%80.84M | 30,298.75%67.21M | -6.78%1.99M | --2.29M | 431.18%25.52M | 692.41%23.16M | -88.24%221.08K | --2.13M | --0 |
| Proceeds from stock option exercised by employees | 596.85%450.17K | 8,091.48%247.96K | --121K | 40.82%81.22K | --0 | -8.11%64.6K | -88.50%3.03K | --0 | 284.37%57.68K | -85.82%3.9K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 497.23%152.77M | 250.01%81.09M | 30,353.48%67.33M | -5.53%2.07M | 58,699.59%2.29M | 424.84%25.58M | 685.45%23.17M | -88.25%221.08K | 14,481.33%2.19M | -85.82%3.9K |
| Net cash flow | ||||||||||
| Beginning cash position | 53.02%14.69M | 661.05%68.38M | 8.65%10.69M | -41.40%6.21M | 53.02%14.69M | -72.47%9.6M | 6.79%8.98M | -40.00%9.84M | -81.82%10.61M | -72.47%9.6M |
| Current changes in cash | -166.93%-3.41M | -1,099.80%-57.09M | 6,867.31%57.69M | 682.22%4.47M | -946.09%-8.48M | 120.14%5.09M | 380.01%5.71M | 89.32%-852.47K | 98.17%-768.4K | -95.73%1M |
| End cash Position | -23.19%11.29M | -23.19%11.29M | 661.05%68.38M | 8.65%10.69M | -41.40%6.21M | 53.02%14.69M | 53.02%14.69M | 6.79%8.98M | -40.00%9.84M | -81.82%10.61M |
| Free cash flow | -50.25%-41.53M | -26.03%-15.53M | -24.13%-11.7M | -28.16%-12.37M | -151.44%-1.93M | -1,875.58%-27.64M | -51.68%-12.32M | -38.93%-9.43M | -38.77%-9.65M | -83.96%3.76M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |